BBTX SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0002085929-26-000014
BBTX filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 5, 2026. A Schedule 13G was filed regarding beneficial ownership of Bambusa Therapeutics, Inc. (BBTX), accompanied by a joint filing agreement.
Summary of the filing
A Schedule 13G was filed regarding beneficial ownership of Bambusa Therapeutics, Inc. (BBTX), accompanied by a joint filing agreement. The filing indicates a passive investor position.
Key details
✦ Ask GOAX AI about this filing — what it means for BBTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BBTX?
Click hereFrequently asked questions
What did BBTX file with the SEC on Nov 5, 2026?
BBTX filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding beneficial ownership of Bambusa Therapeutics, Inc. (BBTX), accompanied by a joint filing agreement. The filing indicates a passive investor position.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
Other BBTX SEC filings
Get alerts when BBTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days